Clin2
NCT07856654Possibly a fitNot yet recruiting

Pain relief after pelvic surgery

Pelvic Organ Prolapse (POP)Postoperative PainUrogynecology

Treatments studied

Part of Pain clinical trials.

This study tests a new non-opioid pain medicine called suzetrigine for pain after certain types of pelvic surgery. If it works, it might help you recover with fewer side effects than opioids.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
48 people
Ages
40 years to 80 years
Study type
Interventional

Who can take part

  • You are a woman aged 40 to 80.
  • Your weight is in a range that corresponds to a body mass index (BMI) between 18 and 40.
  • You are having one of these specific pelvic surgeries: robotic sacrocolpopexy, uterine suspension, or similar prolapse repair.
  • You have not used opioids in the past month and are not regularly using them now.
  • You can speak and read English or Spanish and can receive text messages on your phone.
  • You do not have severe liver, kidney, or heart problems, and you are not pregnant or planning to become pregnant.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07600697Not yet recruiting· Phase 4
Non-opioid pain medicine after vaginal pelvic surgery

This study tests a new non-opioid pain medicine called suzetrigine to see if it can control pain after vaginal pelvic surgery while reducing the need for opioid painkillers. If you are having this type of surgery soon, this trial might offer you an alternative for pain management.

Los Angeles, California
NCT07836010Not yet recruiting· Phase 4
Added pain medicine for women having minimally invasive hysterectomy

This study tests whether adding suzetrigine to standard pain relief improves recovery after minimally invasive hysterectomy. Suzetrigine is a new type of painkiller that may reduce the need for opioids.

NCT07829718Not yet recruiting· Phase 4
Testing a new pain medicine after lower back fusion surgery

This study tests a non-opioid pain medicine called suzetrigine (also known as Journavx) to see how well it controls pain after lower back surgery. It might be a good option if you're having lumbar fusion surgery and want to avoid the side effects of opioid painkillers.

NCT07795827Not yet recruiting· Phase 4
Suzetrigine for pain after ankle replacement

This study tests a new non-opioid pain medicine called suzetrigine to see how well it controls pain after ankle replacement surgery. The goal is to manage pain with fewer opioid-related side effects.

NCT07821931Not yet recruiting· Phase 4
Pain relief after tonsillectomy with suzetrigine

This study tests a new pain medicine, suzetrigine, to see if it can reduce the need for opioids after a tonsillectomy or similar throat surgery. It aims to provide effective pain control with fewer opioid-related risks.

Palo Alto, California
NCT07534709Not yet recruiting· Phase 4
A new non-opioid painkiller for recovery after C-section

This study tests a new non-opioid pain medicine called suzetrigine to help women recover from C-section without relying on opioids. If you're having a C-section and want to manage pain during recovery with a non-opioid option, this trial may be a good fit.

Austin, Texas

Hear when a new Postoperative Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.